Showing 1 - 10 of 17
Persistent link: https://www.econbiz.de/10009259522
Persistent link: https://www.econbiz.de/10009703635
Persistent link: https://www.econbiz.de/10003285372
Persistent link: https://www.econbiz.de/10003436733
Persistent link: https://www.econbiz.de/10008806604
Persistent link: https://www.econbiz.de/10010511605
Persistent link: https://www.econbiz.de/10011432054
Persistent link: https://www.econbiz.de/10010243065
Persistent link: https://www.econbiz.de/10011434021
Background: The necessity to measure and reward "value for money" of new pharmaceuticals has become central in health policy debates, as much as the requirement to assess the "willingness to pay" for an additional, qualityadjusted life year (QALY). There is a clear need to understand the...
Persistent link: https://www.econbiz.de/10012291180